NO20073787L - Nye pyrimidin-nukleosidforbindelser eller dets salt - Google Patents

Nye pyrimidin-nukleosidforbindelser eller dets salt

Info

Publication number
NO20073787L
NO20073787L NO20073787A NO20073787A NO20073787L NO 20073787 L NO20073787 L NO 20073787L NO 20073787 A NO20073787 A NO 20073787A NO 20073787 A NO20073787 A NO 20073787A NO 20073787 L NO20073787 L NO 20073787L
Authority
NO
Norway
Prior art keywords
group
pyrimidine nucleoside
nucleoside compounds
alkyl group
salt
Prior art date
Application number
NO20073787A
Other languages
English (en)
Inventor
Makoto Nomura
Yayoi Ono
Original Assignee
Sasaki Takuma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sasaki Takuma filed Critical Sasaki Takuma
Publication of NO20073787L publication Critical patent/NO20073787L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Nye pyrimidinnukleosidforbindelser representert ved den følgende formel (1): [F1] (hvor én av X og Y representerer en cyanogruppe og den andre representerer et hydrogenatom; én av R1 og R2 representerer et hydrogenatom, en karbonylgruppe som har en C1-C6-alkylgruppe som er mono-substituert med en aminogruppe eller en gruppe representert ved (R3)(R4)(R5)Si-, og den andre representerer en silylgruppe representert ved (R6)(R7)(R8)Si-, eller R1 og R2 danner sammen en 6-leddet cyklisk gruppe representert ved -Si(R9)(R10)-; R3, R4, R5, R6, R7 og R8 hver representerer en alkylgruppe, en cyklisk alkylgruppe, en arylgruppe eller en alkylgruppe som er substituert med én eller to arylgrupper; og R9 og R10 hver representerer en alkylgruppe) eller et salt derav. De nye pyrimidinnukleosidforbindelsene oppviser utmerket anti-tumoreffekt sammenlignet med eksisterende pyrimidinnukleosidforbindelser.
NO20073787A 2005-01-31 2007-07-20 Nye pyrimidin-nukleosidforbindelser eller dets salt NO20073787L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005023278 2005-01-31
PCT/JP2006/301483 WO2006080509A1 (ja) 2005-01-31 2006-01-30 新規ピリミジンヌクレオシド化合物又はその塩

Publications (1)

Publication Number Publication Date
NO20073787L true NO20073787L (no) 2007-09-27

Family

ID=36740526

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073787A NO20073787L (no) 2005-01-31 2007-07-20 Nye pyrimidin-nukleosidforbindelser eller dets salt

Country Status (15)

Country Link
US (1) US7825103B2 (no)
EP (1) EP1845102A4 (no)
JP (1) JP4966186B2 (no)
KR (1) KR20070103012A (no)
CN (1) CN101111509B (no)
AU (1) AU2006209422B2 (no)
BR (1) BRPI0607287A2 (no)
CA (1) CA2596060A1 (no)
IL (1) IL184779A0 (no)
MY (1) MY142304A (no)
NO (1) NO20073787L (no)
NZ (1) NZ560252A (no)
RU (1) RU2395517C2 (no)
TW (1) TW200637870A (no)
WO (1) WO2006080509A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100216736A2 (en) 2006-07-21 2010-08-26 Taiho Pharmaceutical Co., Ltd. 2'-cyanopyrimidine nucleoside compound
GB0625283D0 (en) 2006-12-19 2007-01-24 Cyclacel Ltd Combination
EP2147009A4 (en) * 2007-05-18 2014-01-08 Dharmacon Inc NOVEL CHROMOPHORE SILYL PROTECTION GROUPS AND THEIR USE IN THE CHEMICAL SYNTHESIS OF OLIGONUCLEOTIDES
CN101787066B (zh) * 2009-01-23 2013-07-31 高峰 阿糖胞苷衍生物及其在抗癌抗肿瘤中的用途
US10889555B2 (en) 2016-05-31 2021-01-12 Taiho Pharmaceutical Co., Ltd. Sulfonamide compound or salt thereof
ES2982299T3 (es) * 2016-05-31 2024-10-15 Taiho Pharmaceutical Co Ltd Compuestos de sulfonamida o sal de los mismos como inhibidores de ribonucleótido reductasa para el tratamiento del cáncer
WO2018230479A1 (ja) * 2017-06-13 2018-12-20 大原薬品工業株式会社 ヌクレオシド系抗がん剤又は抗ウィルス剤の5'位シリルエーテル誘導体
TWI748142B (zh) * 2017-11-29 2021-12-01 日商大鵬藥品工業股份有限公司 抗腫瘤劑
AU2018377036B2 (en) 2017-11-29 2022-04-14 Taiho Pharmaceutical Co., Ltd. Sulfonamide compounds and use thereof
KR20190065139A (ko) * 2017-12-01 2019-06-11 압타바이오 주식회사 혈액암 치료제

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587500T2 (de) 1984-12-04 1993-12-16 Lilly Co Eli Tumorbehandlung bei Säugetieren.
ZA859008B (en) * 1984-12-04 1987-07-29 Lilly Co Eli The treatment of tumors in mammals
DE68920304T2 (de) * 1988-07-11 1995-05-11 Taiho Pharmaceutical Co Ltd 5-substituierte uridinderivate und zwischenprodukte.
JP2559917B2 (ja) * 1990-06-15 1996-12-04 三共株式会社 ピリミジンヌクレオシド誘導体
JP2664837B2 (ja) * 1991-06-07 1997-10-22 三井東圧化学株式会社 トリフルオロチミジン誘導体、その製造法およびそれを有効成分とする制ガン剤
FI105556B (fi) * 1991-09-30 2000-09-15 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta
JPH07179491A (ja) 1993-12-22 1995-07-18 Sankyo Co Ltd 5’−ホスファチジルピリミジンヌクレオチド誘導体
JP2003113197A (ja) 2001-10-09 2003-04-18 Mitsui Chemicals Inc シチジンヌクレオシド誘導体の製造法
CN1701367A (zh) 2003-05-23 2005-11-23 富士通株式会社 磁光记录介质及其制造方法以及磁光记录介质驱动器

Also Published As

Publication number Publication date
AU2006209422B2 (en) 2010-08-12
MY142304A (en) 2010-11-15
RU2395517C2 (ru) 2010-07-27
NZ560252A (en) 2009-10-30
JP4966186B2 (ja) 2012-07-04
BRPI0607287A2 (pt) 2009-08-25
EP1845102A1 (en) 2007-10-17
WO2006080509A1 (ja) 2006-08-03
CN101111509B (zh) 2011-02-16
TW200637870A (en) 2006-11-01
JPWO2006080509A1 (ja) 2008-06-19
AU2006209422A1 (en) 2006-08-03
CA2596060A1 (en) 2006-08-03
KR20070103012A (ko) 2007-10-22
US7825103B2 (en) 2010-11-02
IL184779A0 (en) 2007-12-03
US20090118222A1 (en) 2009-05-07
CN101111509A (zh) 2008-01-23
RU2007132737A (ru) 2009-03-10
EP1845102A4 (en) 2012-07-04

Similar Documents

Publication Publication Date Title
DOP2011000061A (es) Compuestos de pirrol
NZ595260A (en) 1-Aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
EP1795536A4 (en) PHOSPHORAMIDITE COMPOUND AND PROCESS FOR THE PREPARATION OF OLIGO RNA
NO20065830L (no) Substituerte 2-kinolyloksazoler som er anvendbare som PDE4-inhibitorer.
TW200604175A (en) Ortho substituted aryl or heteroaryl amide compounds
JO2925B1 (en) New pyridine derivatives and pyrimidine derivatives (3)
MX2010004893A (es) Compuesto heterociclico y composicion farmaceutica del mismo.
EP1845081A4 (en) amide
EA201171328A1 (ru) Производное замещенного изохинолина
AR087792A1 (es) Compuestos heterociclicos tetraciclicos y metodos para el uso de los mismos en el tratamiento de enfermedades virales
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
CY1115635T1 (el) Παραγωγα 2-πυριδιν-2-υλο-πυραζολ-3(2η)-ονης, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη
AR062798A1 (es) Derivados de hexahidropirrolo[3,4-c]pirrol antiviricos
CY1111748T1 (el) Παραγωγα 7-αλκυνυλο-1.8-ναφθυριδονων, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη
CO5700768A2 (es) Derivados de benzoxazina y sus usos
BRPI0506927A (pt) compostos orgánicos
NO20060142L (no) Syklisk tertiaer aminforbindelse
DK1706414T3 (da) Fremgangsmåde til fluorcytidinderivater
EA201171012A1 (ru) Производные 5-фторбензотиазолов и 5-фторбензимидазолов, содержащие 6-замещенный триазолопиридазинсульфанил в положении 6: получение, применение в качестве лекарственных средств и применение в качестве ингибиторов met
TW200637870A (en) Novel pyrimidine nucleoside compound and salt thereof
TNSN07439A1 (en) Derivatives of,4,5 - diarylpyrrole, preparation method thereof and use of same in therapeutics
EA200300458A1 (ru) Новые соединения аминотриазолона, способ их получения и фармацевтические композиции, содержащие их
EP2045258A4 (en) 3y-ETHYNYLCYTIDINDERIVAT
BR112013024899A2 (pt) derivados de 3-ureidoisoquinolin-8-ila
NO20065323L (no) 6-substituerte pyridoindolonderivater, fremstilling og anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application